These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 312771

  • 1. Immunosuppression in experimental African trypanosomiasis. Polyclonal B-cell activation and mitogenicity of trypanosome-derived saturated fatty acids.
    Assoku RK, Hazlett CA, Tizard I.
    Int Arch Allergy Appl Immunol; 1979; 59(3):298-307. PubMed ID: 312771
    [Abstract] [Full Text] [Related]

  • 2. The immunosuppressive and mitogenic effects of Trypanosoma musculi.
    Hazlett CA, Tizard IR.
    Clin Exp Immunol; 1978 Aug; 33(2):225-31. PubMed ID: 363314
    [Abstract] [Full Text] [Related]

  • 3. Trypanosoma congolense: B-lymphocyte responses differ between trypanotolerant and trypanosusceptible cattle.
    Taylor KA, Lutje V, Kennedy D, Authié E, Boulangé A, Logan-Henfrey L, Gichuki B, Gettinby G.
    Exp Parasitol; 1996 Jun; 83(1):106-16. PubMed ID: 8654538
    [Abstract] [Full Text] [Related]

  • 4. Suppressor cells and loss of B-cell potential in mice infected with Trypanosoma brucei.
    Corsini AC, Clayton C, Askonas BA, Ogilvie BM.
    Clin Exp Immunol; 1977 Jul; 29(1):122-31. PubMed ID: 302169
    [Abstract] [Full Text] [Related]

  • 5. Parasite- (antigen) specific stimulation of B and T cells in African trypanosomiasis.
    Campbell GH, Esser KM, Phillips SM.
    J Immunol; 1982 Sep; 129(3):1272-4. PubMed ID: 6980921
    [Abstract] [Full Text] [Related]

  • 6. Immune depression in trypanosome-infected mice. II. Characterization of the spleen cell types involved.
    Roelants GE, Pearson TW, Tyrer HW, Mayor-Withey KS, Lundin LB.
    Eur J Immunol; 1979 Mar; 9(3):195-9. PubMed ID: 156119
    [Abstract] [Full Text] [Related]

  • 7. Functional depletion of T- and B-memory cells and other lymphoid cell subpopulations-during trypanosomiasis.
    Askonas BA, Corsini AC, Clayton CE, Ogilvie BM.
    Immunology; 1979 Feb; 36(2):313-21. PubMed ID: 155650
    [Abstract] [Full Text] [Related]

  • 8. Mice varying in resistance to African trypanosomiasis respond differently to treatments with variant surface glycoprotein.
    Diffley P.
    Eur J Immunol; 1985 Apr; 15(4):321-4. PubMed ID: 3872799
    [Abstract] [Full Text] [Related]

  • 9. Trypanosomal surface coat variant antigen causes polyclonal lymphocyte activation.
    Diffley P.
    J Immunol; 1983 Oct; 131(4):1983-6. PubMed ID: 6604754
    [Abstract] [Full Text] [Related]

  • 10. Antibody responses in resistant and susceptible inbred mice infected with Trypanosoma congolense.
    Mitchell LA, Pearson TW.
    Immunology; 1986 Feb; 57(2):297-303. PubMed ID: 3949371
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of self-cure from Trypanosoma congolense infection in mice.
    Pinder M, Chassin P, Fumoux F.
    J Immunol; 1986 Feb 15; 136(4):1427-34. PubMed ID: 3484768
    [Abstract] [Full Text] [Related]

  • 12. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins.
    Schleifer KW, Mansfield JM.
    J Immunol; 1993 Nov 15; 151(10):5492-503. PubMed ID: 8228241
    [Abstract] [Full Text] [Related]

  • 13. Immune depression in trypanosome-infected mice. IV. Kinetics of suppression and alleviation by the trypanocidal drug Berenil.
    Roelants GE, Pearson TW, Morrison WI, Mayor-Withey KS, Lundin LB.
    Clin Exp Immunol; 1979 Sep 15; 37(3):457-69. PubMed ID: 159793
    [Abstract] [Full Text] [Related]

  • 14. Lymphocyte function in experimental African trypanosomiasis. VI. Parasite-specific immunosuppression.
    Dempsey WL, Mansfield JM.
    J Immunol; 1983 Jun 15; 130(6):2896-8. PubMed ID: 6189901
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. B lymphocytes of mice display an aberrant activation phenotype and are cell cycle arrested in G0/G1A during acute infection with Trypanosoma brucei.
    Sacco RE, Hagen M, Donelson JE, Lynch RG.
    J Immunol; 1994 Aug 15; 153(4):1714-23. PubMed ID: 7519210
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Free fatty acids, complement activation, and polyclonal B-cell stimulation as factors in the immunopathogenesis of African trypanosomiasis.
    Assoku RK, Tizard IR, Neilsen KH.
    Lancet; 1977 Nov 05; 2(8045):956-9. PubMed ID: 72292
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.